| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 1.036 | 2.278 | 2.784 | 2.833 |
| Total Income - EUR | - | - | - | - | - | - | 1.036 | 2.278 | 2.784 | 2.833 |
| Total Expenses - EUR | - | - | - | - | - | - | 2.085 | 2.640 | 2.785 | 2.988 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | -1.049 | -362 | -1 | -156 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | -1.080 | -430 | -1 | -156 |
| Employees | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Acularmed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 17 | 9 | 1 | 0 |
| Current Assets | - | - | - | - | - | - | 569 | 455 | 705 | 677 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 443 | 445 | 446 | 456 |
| Cash | - | - | - | - | - | - | 126 | 11 | 260 | 222 |
| Shareholders Funds | - | - | - | - | - | - | -1.040 | -1.473 | -1.470 | -1.617 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 1.626 | 1.937 | 2.176 | 2.294 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Acularmed S.r.l.